Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase.

Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Park SH, Kim SK.

Eur J Cancer. 2014 Jan;50(1):137-49. doi: 10.1016/j.ejca.2013.09.004. Epub 2013 Oct 5.

PMID:
24103144
2.

Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.

Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N.

J Urol. 2012 Jul;188(1):294-9. doi: 10.1016/j.juro.2012.02.2555. Epub 2012 May 16.

PMID:
22608744
3.

Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.

Doherty RE, Haywood-Small SL, Sisley K, Cross NA.

Biochem Biophys Res Commun. 2011 Nov 4;414(4):801-7. doi: 10.1016/j.bbrc.2011.10.010. Epub 2011 Oct 8.

PMID:
22005464
4.

Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.

Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, Kunisada T, Yano M, Kuji S, Hirashima Y, Arakawa A, Nishio S, Ushijima K, Ito K, Itani Y, Morishige K.

Gynecol Oncol. 2015 May;137(2):299-305. doi: 10.1016/j.ygyno.2014.12.005. Epub 2014 Dec 23.

PMID:
25541259
5.

Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.

Choi SA, Choi JW, Wang KC, Phi JH, Lee JY, Park KD, Eum D, Park SH, Kim IH, Kim SK.

Neuro Oncol. 2015 Jun;17(6):810-21. doi: 10.1093/neuonc/nou305. Epub 2014 Nov 4.

6.

Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.

Michishita M, Akiyoshi R, Suemizu H, Nakagawa T, Sasaki N, Takemitsu H, Arai T, Takahashi K.

Vet J. 2012 Aug;193(2):508-13. doi: 10.1016/j.tvjl.2012.01.006. Epub 2012 Feb 10.

PMID:
22326935
7.

Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.

Soehngen E, Schaefer A, Koeritzer J, Huelsmeyer V, Zimmer C, Ringel F, Gempt J, Schlegel J.

Brain Tumor Pathol. 2014 Oct;31(4):247-56. doi: 10.1007/s10014-013-0170-0. Epub 2013 Nov 6.

PMID:
24197864
8.

STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.

Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.

Cancer Res. 2011 Dec 1;71(23):7226-37. doi: 10.1158/0008-5472.CAN-10-4660. Epub 2011 Sep 7.

9.

Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity.

Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N, Comi GP.

Stem Cells. 2006 Apr;24(4):975-85. Epub 2005 Nov 17.

10.

Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.

Zou B, Sun S, Qi X, Ji P.

Mol Med Rep. 2012 Apr;5(4):1116-20. doi: 10.3892/mmr.2012.781. Epub 2012 Feb 3.

11.

The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.

Li D, Zhang T, Gu W, Li P, Cheng X, Tong T, Wang W.

Oncol Rep. 2015 May;33(5):2291-8. doi: 10.3892/or.2015.3842. Epub 2015 Mar 9.

PMID:
25760144
12.

The expression of ALDH1 in cervical carcinoma.

Yao T, Chen Q, Zhang B, Zhou H, Lin Z.

Med Sci Monit. 2011 Aug;17(8):HY21-26.

13.

Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.

Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K.

J Pathol. 2012 Nov;228(3):391-404. doi: 10.1002/path.4020. Epub 2012 May 8.

PMID:
22430847
14.

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.

Adams A, Warner K, Pearson AT, Zhang Z, Kim HS, Mochizuki D, Basura G, Helman J, Mantesso A, Castilho RM, Wicha MS, Nör JE.

Oncotarget. 2015 Sep 29;6(29):26633-50. doi: 10.18632/oncotarget.5782.

15.

Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.

Michishita M, Otsuka A, Nakahira R, Nakagawa T, Sasaki N, Arai T, Takahashi K.

Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):73-81. doi: 10.1016/j.vetimm.2013.08.006. Epub 2013 Aug 27.

PMID:
24041801
16.

Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.

Nishikawa S, Konno M, Hamabe A, Hasegawa S, Kano Y, Ohta K, Fukusumi T, Sakai D, Kudo T, Haraguchi N, Satoh T, Takiguchi S, Mori M, Doki Y, Ishii H.

Int J Oncol. 2013 Apr;42(4):1437-42. doi: 10.3892/ijo.2013.1837. Epub 2013 Feb 22.

PMID:
23440340
17.

Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.

Liang D, Shi Y.

Med Oncol. 2012 Jun;29(2):633-9. doi: 10.1007/s12032-011-9933-9. Epub 2011 Apr 12.

PMID:
21484084
18.

Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, DeLeo AB, Wang X.

Clin Cancer Res. 2011 Oct 1;17(19):6174-84. doi: 10.1158/1078-0432.CCR-11-1111. Epub 2011 Aug 19.

19.

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL.

Mol Cancer Res. 2009 Mar;7(3):330-8. doi: 10.1158/1541-7786.MCR-08-0393. Epub 2009 Mar 10.

20.

Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.

Sharrow AC, Perkins B, Collector MI, Yu W, Simons BW, Jones RJ.

Gynecol Oncol. 2016 Aug;142(2):341-8. doi: 10.1016/j.ygyno.2016.03.022. Epub 2016 Jun 11.

PMID:
27017984

Supplemental Content

Support Center